Rockwell Medical Stock Price

-0.0309 (-3.12%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Rockwell Medical Inc RMTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0309 -3.12% 0.96 00:00:05
Close Price Low Price High Price Open Price Previous Close
0.96 0.9402 0.995 0.995 0.9909
Bid Price Ask Price Spread News
0.51 1.24 0.73 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,836 1,267,878 $ 0.9581871 $ 1,214,864 2,634,405 0.9402 - 3.85
Last Trade Time Type Quantity Stock Price Currency
17:09:14 formt 1,445 $ 0.96 USD

Rockwell Medical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 88.43M 92.12M 79.56M $ 61.30M $ -28.78M -0.56 -3.07
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 24.68k 7.30%

more financials information »

Rockwell Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RMTI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.081.100.94021.031,080,410-0.12-11.11%
1 Month1.10761.160.94021.071,375,245-0.1476-13.33%
3 Months1.761.890.94021.311,866,800-0.80-45.45%
6 Months2.342.52940.94021.511,162,696-1.38-58.97%
1 Year2.413.850.94021.961,055,940-1.45-60.17%
3 Years7.067.210.94022.80544,066-6.10-86.4%
5 Years10.2413.070.94024.18461,814-9.28-90.63%

Rockwell Medical Description

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of the hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products. The majority of the revenue is generated form the United States.

Your Recent History
Rockwell M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.